Thursday, July 9, 2026

pharma · Osteopenia · Heat Stress · PTPI

Petros Pharmaceuticals

Petros Pharmaceuticals clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

New York, USA HQ
3 Employees
Public company Type
PTPI · NYSE Ticker
Company details
Status
Public
HQ
New York, USA
Employees
3
Programs
3
Drugs
3
Patents
0
Intelligence · Clinical Programs

Petros Pharmaceuticals projects

3 ClinicalTrials.gov programs sponsored by Petros Pharmaceuticals.

Petros Pharmaceuticals has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Colostrum supplementation for bone loss

    Petros Pharmaceuticals

    Osteopenia

    other completed

    1 trial
  2. Neutral environment with radiation

    Petros Pharmaceuticals

    Heat Stress

    other completed

    1 trial
  3. Thermal stress and performance without a pre-cooling protocol

    Petros Pharmaceuticals

    Risk of Heat Stress

    mab completed

    1 trial

Frequently asked questions

How many clinical projects does Petros Pharmaceuticals have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.